Doctor Saurabh Sethi reveals the worst foods for your gut health, from bloating to acid reflux. Here’s what to avoid for a ...

Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.

“I’ve learned so much from Bart and from the other people on those calls,” said Dr. Rishindra Reddy, a professor ... evolved from heartburn to acid reflux to eventually become stage-three ...

In October, Dr Reddy’s Laboratories launched Elobixibat in India ... Vonoprazan is a next-generation drug used in the treatment of stomach ulcers and gastroesophageal reflux disease (acid reflux).

This position could be particularly beneficial for those battling acid reflux or respiratory issues. Dr Palleti Siva Karthik Reddy, consultant physician at Koshys Hospital, notes, “Gravity plays a ...

This nod came after Dr. Reddy’s laboratories presented the bioequivalence study ... Esomeprazole is indicated for the treatment of acid-reflux disorders, including healing and maintenance of erosive ...

Dr Reddy's Laboratories has in 2022 announced an exclusive partnership ... and market of Tegoprazan tablet 50 mg for the indications of erosive gastroesophageal reflux disease (GERD), non-erosive ...

Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report by ...

Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories has expanded its global footprint by establishing a new wholly-owned subsidiary, Dr. Reddy’s Denmark ApS ...

Dr. Reddy’s Laboratories has signed a non-exclusive ... orally active potassium competitive acid blockers (PCAB), are used to treat reflux esophagitis and other acid peptic disorders.

In recent years, Dr. Reddy’s has increased its presence in consumer healthcare (nutrition and OTC wellness) in markets around the world, including a recent joint venture with Nestlé India ...

Dr Reddy's share price: Dr Reddy's said that its net profit was 3% lower sequentially compared to ₹13,738 crore seen in the December'2023 quarter. Dr Reddy's share price: Dr Reddy’s ...